AKR1C3 overexpression may serve as a promising biomarker for prostate cancer progression-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

AKR1C3 overexpression may serve as a promising biomarker for prostate cancer progression

Published:2014-02-26 Issue:1 Volume:9 Page:
ISSN:1746-1596
Container-title:Diagnostic Pathology
language:en
Short-container-title:Diagn Pathol

Author:

Tian Yuantong,Zhao Lijing,Zhang Haitao,Liu Xichun,Zhao Lijuan,Zhao Xuejian,Li Yi,Li Jing

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Histology,Pathology and Forensic Medicine

Link

https://link.springer.com/content/pdf/10.1186/1746-1596-9-42.pdf

Reference28 articles.

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D: Global cancer statistics. CA Cancer J Clin. 2011, 61 (2): 69-90. 10.3322/caac.20107.

2. Crawford ED, Eisenberger MA, McLeod DG, Spaulding JT, Benson R, Dorr FA, Blumenstein BA, Davis MA, Goodman PJ: A controlled trial of leuprolide with and without flutamide in prostatic carcinoma. N Engl J Med. 1989, 321 (7): 419-424. 10.1056/NEJM198908173210702.

3. Eisenberger MA, Blumenstein BA, Crawford ED, Miller G, McLeod DG, Loehrer PJ, Wilding G, Sears K, Culkin DJ, Thompson IM, Bueschen AJ, Lowe BA: Bilateral orchiectomy with or without flutamide for metastatic prostate cancer. N Engl J Med. 1998, 339 (15): 1036-1042. 10.1056/NEJM199810083391504.

4. Hellerstedt BA, Pienta KJ: The current state of hormonal therapy for prostate cancer. CA Cancer J Clin. 2002, 52 (3): 154-179. 10.3322/canjclin.52.3.154.

5. Knudsen KE, Penning TM: Partners in crime: deregulation of AR activity and androgen synthesis in prostate cancer. Trends Endocrinol Metab. 2010, 21 (5): 315-324. 10.1016/j.tem.2010.01.002.

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer to Cataracts: The Mechanistic Impact of Aldo-Keto Reductases in Chronic Diseases;The Yale Journal of Biology and Medicine;2024-06-28

2. CYP17A1 Network Analysis in Ovarian Serous Cystadenocarcinoma for Retrieval of Polycystic ovaries Targets;Albus Scientia;2024-05-22

3. Evolution of the HIF targeted therapy in clear cell renal cell carcinoma;Cancer Treatment Reviews;2023-12

4. Influence of aldo–keto reductase 1C3 polymorphisms in early-onset female psoriasis patients;Scientific Reports;2023-02-25

5. Establishing a Proteomics-Based Signature of AKR1C3-Related Genes for Predicting the Prognosis of Prostate Cancer;International Journal of Molecular Sciences;2023-02-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3